Terms: = Head and neck cancer AND JAK1, ENSG00000162434, P23458, JTK3, JAK1B, JAK1A, 3716 AND Prognosis
6 results:
1. DACH1 regulates macrophage activation and tumour progression in hypopharyngeal squamous cell carcinoma.
Li W; Xu L; Cao J; Ge J; Liu X; Liu P; Teng Y; Wang S; Sun Y; Liu M; Tian L
Immunology; 2023 Oct; 170(2):253-269. PubMed ID: 37243970
[TBL] [Abstract] [Full Text] [Related]
2. DUSP4 promotes esophageal squamous cell carcinoma progression by dephosphorylating HSP90β.
Zhou L; Yao N; Yang L; Liu K; Qiao Y; Huang C; Du R; Yeung YT; Liu W; Cheng D; Dong Z; Li X
Cell Rep; 2023 May; 42(5):112445. PubMed ID: 37141098
[TBL] [Abstract] [Full Text] [Related]
3. jak1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung cancer.
Shien K; Papadimitrakopoulou VA; Ruder D; Behrens C; Shen L; Kalhor N; Song J; Lee JJ; Wang J; Tang X; Herbst RS; Toyooka S; Girard L; Minna JD; Kurie JM; Wistuba II; Izzo JG
Mol Cancer Ther; 2017 Oct; 16(10):2234-2245. PubMed ID: 28729401
[TBL] [Abstract] [Full Text] [Related]
4. Clinicobiological progression and prognosis of oral squamous cell carcinoma in relation to the tumor invasive front: impact on prognosis.
Sandu K; Nisa L; Monnier P; Simon C; Andrejevic-Blant S; Bron L
Acta Otolaryngol; 2014 Apr; 134(4):416-24. PubMed ID: 24628337
[TBL] [Abstract] [Full Text] [Related]
5. JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma.
You Z; Xu D; Ji J; Guo W; Zhu W; He J
Clin Transl Oncol; 2012 Feb; 14(2):143-9. PubMed ID: 22301404
[TBL] [Abstract] [Full Text] [Related]
6. Quantitative chemical proteomics reveals new potential drug targets in head and neck cancer.
Wu Z; Doondeea JB; Gholami AM; Janning MC; Lemeer S; Kramer K; Eccles SA; Gollin SM; Grenman R; Walch A; Feller SM; Kuster B
Mol Cell Proteomics; 2011 Dec; 10(12):M111.011635. PubMed ID: 21955398
[TBL] [Abstract] [Full Text] [Related]
